Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 158

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial

Open access
Buitenwerf, Edward, Osinga, Thamara E, Timmers, Henri J L M, Lenders, Jacques W M, Feelders, Richard A, Eekhoff, Elisabeth M W, Haak, Harm R, Corssmit, Eleonora P M, Bisschop, Peter H L T, Valk, Gerlof D, Veldman, Ronald Groote, Dullaart, Robin P F, Links, Thera P, Voogd, Magiel F, Wietasch, Götz J K G, Kerstens, Michiel N · 2020 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Pretreatment with α-adrenergic receptor blockers is recommended to prevent hemodynamic instability during resection of a pheochromocytoma or sympathetic paraganglioma (PPGL). Objective: To determine which type of α-adrenergic receptor blocker provides the best efficacy. Design: Randomized controlled open-label trial (PRESCRIPT; ClinicalTrials.gov NCT01379898) Setting: Multicenter study including 9 centers in The Netherlands. Patients: 134 patients with nonmetastatic PPGL. Intervention: Phenoxybenzamine or doxazosin starting 2 to 3 weeks before surgery using a blood pressure targeted titration schedule. Intraoperative hemodynamic management was standardized. Main Outcome Measures: Primary efficacy endpoint was the cumulative intraoperative time outside the blood pressure target range (ie, SBP >160 mmHg or MAP <60 mmHg) expressed as a percentage of total surgical procedure time. Secondary efficacy endpoint was the value on a hemodynamic instability score. Results: Median cumulative time outside blood pressure targets was 11.1% (interquartile range [IQR]: 4.3–20.6] in the phenoxybenzamine group compared to 12.2% (5.3–20.2)] in the doxazosin group (P = .75, r = 0.03). The hemodynamic instability score was 38.0 (28.8–58.0) and 50.0 (35.3–63.8) in the phenoxybenzamine and doxazosin group, respectively (P = .02, r = 0.20). The 30-day cardiovascular complication rate was 8.8% and 6.9% in the phenoxybenzamine and doxazosin group, respectively (P = .68). There was no mortality after 30 days. Conclusions: The duration of blood pressure outside the target range during resection of a PPGL was not different after preoperative treatment with either phenoxybenzamine or doxazosin. Phenoxybenzamine was more effective in preventing intraoperative hemodynamic instability, but it could not be established whether this was associated with a better clinical outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgz188

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 158

Metadata

Authors
Buitenwerf, E., Osinga, T. E., Timmers, H. J. L. M., Lenders, J. W. M., Feelders, R. A., Eekhoff, E. M. W., Haak, H. R., Corssmit, E. P. M., Bisschop, P. H. L. T., Valk, G. D., Veldman, R. G., Dullaart, R. P. F., Links, T. P., Voogd, M. F., Wietasch, G. J. K. G., & Kerstens, M. N.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-11-12
Volume
105
Issue
7
Pages
2381-2391
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2987229635
Cited by
158
References
3
FWCI
12.96
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1210/clinem/dgz188
The paper
Buitenwerf, E., Osinga, T. E., Timmers, H. J. L. M., Lenders, J. W. M., Feelders, R. A., Eekhoff, E. M. W., Haak, H. R., Corssmit, E. P. M., Bisschop, P. H. L. T., Valk, G. D., Veldman, R. G., Dullaart, R. P. F., Links, T. P., Voogd, M. F., Wietasch, G. J. K. G., & Kerstens, M. N. (2020). Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgz188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.